Valneva SE

About Valneva SE

Valneva is a specialty vaccine company focused on developing, manufacturing, and commercializing prophylactic vaccines for infectious diseases with unmet medical needs. Their mission is to advance vaccines for better lives, leveraging expertise to commercialize vaccines and advance a broad range of vaccine candidates.

Products & Services

Vaccines for Infectious Diseases:Focus on prophylactic vaccines addressing major unmet medical needs, including a single-shot chikungunya vaccine (IXCHIQ®).

Lyme Disease Vaccine (VLA15):A vaccine candidate in development to combat Lyme disease.

Chikungunya Vaccine (VLA1553/IXCHIQ®):A single-shot vaccine for chikungunya with reported long-term seroresponse.

Shigella Vaccine (S4V2):A vaccine candidate targeting Shigella infections.

Marketing and Distribution:Services related to the marketing and distribution of vaccines.

Manufacturing and Services:Manufacturing capabilities and related services for vaccine production.

Specialties

Vaccine Development Infectious Diseases Travel Health Research and Development in Vaccines

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Private Placement T: - FT: Private Placement	A: 67298000 MR: - FA: €61,180,000 FAN: 67298000	D: 2024-09-13 FD: 2024-09-13	2 investors
2	RT: Grant T: - FT: Grant	A: 41300000 MR: - FA: up to $41.3 million FAN: 41300000	D: 2024-07-22 FD: 2024-07-22	2 investors
3	RT: Debt T: - FT: Debt	A: 100000000 MR: - FA: 100 million FAN: 100000000	D: 2024-03-18 FD: 2024-03-18	2 investors
4	RT: Debt T: - FT: Debt	A: 100000000 MR: - FA: Up to $100 million FAN: 100000000	D: 2023-08-17 FD: 2023-08-17	2 investors

Private Placement Latest

2024-09-13

$67.3M

2 investors (Pro only)

Grant 2024-07-22

$41.3M

Debt 2024-03-18

$100.0M

View 3 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

T

Thomas Lingelbach

Chief Executive Officer, Member of the Board of Directors

P

Peter Bühler

Chief Financial Officer

V

Vincent Dequenne

Chief Operating Officer

J

Juan Carlos Jaramillo

Chief Medical Officer

D

Dipal Patel

Chief Commercial Officer

P

Petra Pesendorfer

Chief People Officer

View 11 more team members with Pro

Unlock Full Team Directory

Recent News

Valneva SE Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised